Overview

An in-depth look at the latest legal and regulatory issues in the pharmaceutical and healthcare industry. In this issue, we take a look at:

Sustained release formulation of statin held obvious;

EPO Enlarged Board of Appeal decision on dosage regimes;

EPO Enlarged Board of Appeal decision G 1/07 provides guidance on methods for treatment by surgery;

OFT commences proceedings against Reckitt Benckiser;

Advocate General considers UK prescribing incentive scheme contrary to EU law;

Consultation on the implementation of generic substitution in England;

Servier v Apotex - Will the £17.5m award in favour of Apotex be unravelled?

Product liability: Substitution of parties after longstop date;

SPCs for vaccines: guidance re combination products applies to vaccines;

Shanks -v- Unilever plc: Guidance re employee compensation where employer assigns/licenses to group company; and

Mölnlycke Health Care v BSN Medical: No stay of English proceedings but no interim injunction.

Click to read more.